Specialties
- Hematology/Medical Oncology
Area of focus i
- Gastrointestinal cancers
- Malignant hematology
Affiliated with
1240 S Cedar Crest Blvd
Suite 401
Allentown, PA 18103-6218
United States
In this study, a complete dosing cycle is 28 days (21 days on the study drug with a 7 day rest). If you agree to participate, you will take 2 capsules of BGJ398 125 mg (one 100 mg and one 25 mg capsule) once daily in the morning at approximately the same time (starting on day 1, cycle 1) every day. Blood work will be done every week for the first cycle and then every 2 weeks for the second cycle, and then every 4 weeks for every additional cycle thereafter. Prior to being administered study drug, the following test and procedures will be performed to see if you are eligible (screening) for the study: Collect documentation of your FGFR pathway regulation status; collect demographic information; answer health and medication questions; physical examination; eye examination; check vital signs; collect height and weight; Check your daily living abilities; blood collection; urine collection; pregnancy test; electrocardiogram (ECG - measures the electrical activity of your heart); MUGA Scan or Echocardiogram; CT Scan or MRI; and obtain archival tumor sample or fresh biopsy. Depending on what kind of tumor you have, you may require additional, tumor specific assessments.
1240 S Cedar Crest Blvd
Suite 401
Allentown, PA 18103-6218
United States